Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Fulvestrant in The Treatment of Metastatic Breast Cancer in Premenopausal Women

NCT03591549 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03591549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03591549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Fulvestrant in The Treatment of Metastatic Breast Cancer in Premenopausal Women
Lead sponsor
Assiut University
Phase
Phase 4
Overall status
Unknown status
Start date
August 1, 2018
Completion date
October 1, 2021
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer